Main instruments for the gait analysis used in patients with muscular dystrophy of Duchenne
DOI:
https://doi.org/10.34024/rnc.2007.v15.10278Keywords:
Gait, Muscular Dystrophy Duchenne, Physical TherapyAbstract
Introduction. Among the several diseases that commit the gait, the neuromuscular are one of the main ones, being the locomotion plenty assault in the group of the muscular dystrofhy. The patients with muscular dystrophy of Duchenne (DMD) present several motor compromising, among them alterations in the gait. Being like this, to evaluate the gait in a necessary way is important to analyze the real effects of the physiotherapic interventions applied to the patients with DMD. Objective. The objective of that work is to identify and to characterize the main instruments for the gait analysis used in patients with DMD. Method. We researched in the following bases of data MEDLINE, LILACS, SCIELO, PUBMED, SCIRUS, BASE and DEDALUS. The terms used in the Portuguese language were marcha, locomoção, análise and distrofia muscular de Duchenne, and in the English language they were gait, walking, locomotion, analysis and Duchenne muscular dystrophy. For the selection of the goods inclusion criteria and exclusion were used. Results. The found results were tabulated according to amount of patients, objectives, instruments, and resources. Conclusion. The 14 instruments of gait analysis found are, in his totality, characterized as cinematic, resources that supply kinetic data just existing.
References
Inman VT, Ralston HJ, Todd G. A Locomoção Humana. In: Rose J, Gamble JG. Marcha Humana. 2a ed. São Paulo: Premier; 1998, pp. 1-21.
McArdle WD, Katch FI, Katch VL. Essentials of exercise physiology. 2a ed. Philadelphia: Lippincott Williams & Wilkins, 2000, 537p.
Ishida RS. Nomenclatura em Análise de Marcha. In: Saad M. Análise de Marcha — Manual do CAMO — SBMFR. Comitê de Análise de Movimentos da Sociedade de Medicina Física e Reabilitação. São Paulo: Lemos, 1997, pp. 17-24.
Smith LK, Weiss EL, Lehmkuhl LD. Cinesiologia Clínica de Brunstrom. 5a ed. São Paulo: Manole, 1997, 500p.
O’Sullivan SB, Schmitz TJ. Fisioterapia: Avaliação e Tratamento. 4a ed. São Paulo: Manole, 2004, 307p.
Gross J, Fetto J, Rosen E. Exame Musculoesquelético. Porto Alegre: Artmed, 2000, 438p.
Burns YR, MacDonald J. Fisioterapia e Crescimento na Infância. 1a ed. São Paulo: Santos, 1999, 45p.
Viel E. A Marcha Humana Corrida e o Salto — Biomecânica, investigações, normas e disfunções. 1aed. São Paulo: Manole, 2001, 140p.
Davies PM. Passos a seguir. Um manual para o tratamento da Hemiplegia no adulto. São Paulo: Manole, 1996, 350p.
Shumway-Cook A, Baldwin M, Polissar NL, Gruber W. Predicting the probability for falls in community-dwelling older adults. Phys Ther 1997; 77:812-9.
Ramalho Jr A. Prefácio à edição em português. In: Rose J, Gamble JG. Marcha Humana. 2a ed. São Paulo: Premier, 1993, p. XIII.
Rose J, Gamble JG. Marcha Humana. 2a ed. São Paulo: Premier, 1993.
Battistella LR. A análise do movimento como ferramenta da reabilitação. In: Saad M. Análise de Marcha — Manual do CAMO — SBMFR. Comitê de Análise de Movimentos da Sociedade de Medicina Física e Reabilitação. São Paulo: Lemos, 1997, pp. 5-9.
133. Nelson AJ. Functional ambulation profile. Phys Ther 1974;54:1059.
Van Swearingen JM, Paschal K, Bonino P, Yang J. The Modified Gait Abnormality Rating Scale for recognizing the risk of recurrent falls in community-dwelling elderly adults. Phys Ther 1996;76(9):994-1002.
Stokes M. Neurologia para Fisioterapeutas. São Paulo: Premier, 2000, 117p.
Bach JR. Guia de exames e tratamentos das doenças neuromusculares. São Paulo: Santos, 2004, pp. 5-11.
Sutherland DH, Olshen R, Coopoer L, Wyatt M, Leach J, Scott M, et al. The Pathomechanics of Gait in Duchenne Muscular Dystrophy. Develop Med Child Neurol 1981;23(1):3-22.
Khodadadeh S, McClelland MR, Patrick JH, Edwards RHT, Evans GA. Knee movements in Duchenne Muscular Dystrophy. Lancet 1986;2(8506):544-55.
. Armand S, Mercier M, Watelain E, Patte K, Pelissier J, Rivier F. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait Posture 2005;21:369-78.
Edwards RHT, Chapman SJ, Newham DJ, Jones DA. Practical analysis of variability of muscle function measurements in Duchenne Muscular Dystrophy. Muscle Nerve 1987;10(1):6-14.
Vignos PJ, Wagner MB, Karlinchak B, Katirji B. Evaluation of a Program for Long-Term Treatment of Duchenne Muscular Dystrophy. J Bone Joint Surg Am 1996;78(12):1844-52.
Barret R, Hyde AS, Scott OM, Dubowitz V. Changes in center of gravity in boys with Duchenne Muscular Dystrophy. Muscle Nerve 1988;11(11):1157-63.
Heckmatt JZ, Hyde AS, Gabain A, Dubowitz V. Therapeutic trial of isaxonine in Duchenne Muscular Dystrophy. Muscle Nerve 1988;11(8):836-47.
Thompson N, Robb SA. Rational management of gait pathology in Duchenne Muscular Dystrophy. Gait Posture 1995;3(4):285.
Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F. Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisone theraphy. Eur J Paediatr Neurol 2002;6:153-9.
Hyde SA, Steffensen BF, Floytrup I, Glent S, Kroksmark AK, Salling B, et al. Longitudinal data analysis: an application to construction of a natural history profile of Larson CM, Henderson RC. Bone Mineral 1
Density and Fracture in Boys with Duchenne Muscular Dystrophy. Neuromuscular Disorders 2001;11(2):165-70. 28. Taktak DM, Bowker P. Lightweight, Modular Knee-Ankle-Foot Orthosis for Duchenne Muscular Dystrophy: Design, Development, and Evaluation. Arch Phys Med Rehabil 1995;76(12):1156-62.
Thompson N, Robb SA. The Orthotic Management of Gait Pathology in Duchenne Muscular Dystrophy. Physiotheraphy 1995;81(8):459.
Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, Orcesi S, et al. A multicenter, double-blind, randomized trial of deflazacort versus predinisone in Duchenne Muscular Dystrophy. Muscle Nerve 2000;23(9):1344-7.
Larson CM, Henderson RC. Bone Mineral Density and Fracture in Boys with Duchenne Muscular Dystrophy. J Pediatr Orthop 2000;20(1):71-4.
Cohen L, Morgan J, Babbs R, Karrison TG, Giacomoni M. Fast Walking Velocity in Healthy ans Duchenne Muscular Dystrophy: A Statistical Analysis. Arch Phys Med Rehabil 1984;65(70):573-8.
Bakker JPJ, de Groot IJM, Beelen A, Lankhorst GJ. Predictive factors of cessation of ambulation in patients with Duchenne Muscular Dystrophy. Am J Phys Med Rehabilit 2002;81(12):906-12.
Yilmaz O, Karaduman A, Topaloglu H. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 2004;11(8):541-4.
Patte K, Pélissier J, Bénaim C, Laassel EM, Guibal C, Echenne B. Analyse de la marche au cours de la dystrophie musculaire de Duchenne. Ann Réadaptation Méd Phys 2000;43:57-68.
Rennie DJ, Attfield SF, Morton RE, Polak FJ, Nicholson J. An evaluation of lycra garments in the lower limb using 3-D gait analysis and functional assessment (PEDI). Gait Posture 2000;12:1-6.
Saad M, Tellini GG. Análise Observacional da Marcha. In: Saad M Battistella LR (orgs). Análise de Marcha — Manual do CAMO — SBMFR. Comitê de Análise de Movimentos da Sociedade de Medicina Física e Reabilitação. São Paulo: Lemos, 1997, pp. 37-46.
McDonald CM, Widman LM, Walsh DD, Walsh AS, Abresch RT. Use of Step Activity Monitoring for Continuous Physical Activity Assessment in Boys With Duchenne Muscular Dystrophy. Arch Phys Med Rehabil 2005;86:802-8.
Andriacchi TP, Ogle JA, Galante JO. Walking speed as a basis for normal and abnormal gait measurements. J Biomechan 1977;10:261-8.
Adams JM, Perry J. Análise da Marcha: Aplicação Clínica. In: Rose J, Gamble JG. Marcha Humana. 2a ed. São Paulo: Premier; 1993, pp. 147-74.
Português
English
Español
